Mandatory subjects:
- 2 hours on the validation and counseling of prescriptions for controlled substances and opioids
- 2 hours in medication errors
- 1 hour in HIV/AIDS, one-time only
Additional Information for Renewals:
- Pharmacists certified to administer vaccines or epinephrine auto-injection are required 3 hours on the safe and effective administration of vaccines and epinephrine auto-injection, every two years. Course must be from a statewide professional association of physicians accredited to provide educational activities designated as AMA PRA Category 1 Creditâ„¢.*
- Pharmacists seeking to administer long-acting antipsychotic medication by injection are required to complete an 8-hour course on the safe and effective administration of behavioral health and antipsychotic medications by injection, one-time only. Course must be from a statewide professional association of physicians accredited to provide educational activities designated as AMA PRA Category 1 Creditâ„¢.*
- First Biennium Renewal: If you are renewing your license for the first time AND your initial renewal occurs 12 months or more after initial licensure date you are required to complete 15 (5 must be live) general, 2 medication errors, 2 controlled substances, and 1 hour in HIV/AIDS. If your initial renewal occurs less than 12 months from your initial licensure date you are required to complete 1 hour in HIV/AIDS and 2 hours of controlled substances.
- Consultant Pharmacists are required an additional 24 hours in topics specified in Rule 64B16-26.302 FAC, every two years. A minimum of 3 hours are required on the topics of:
- Drug therapy - disease state;
- Administrative responsibilities;
- Consultant pharmacist facility responsibilities; or
- Compounding sterile or nonsterile human drugs (or both).
- Nuclear Pharmacists are required an additional 24 hours in topics specified in Rule 64B16-26.304 FAC, every two years. Subject matter requirements:
- Applying radiopharmaceutical theory in practice or research setting; providing drug/radiopharmaceutical information in the clinical setting;
- Communicating effectively with patients, nuclear medicine physicians and technologists, radiation safety personnel, other nuclear pharmacists;
- Applying current radiation safety and quality assurance principles with an emphasis on recordkeeping and documentation;
Nuclear pharmacy management; - Advances in drug, radiopharmaceutical, or related technology.
* Please contact the Florida Board of Pharmacy at (850) 245-4474 for additional information.